Bayer
Jan Emiel Mommaertslaan 14
1831 Diegem
BE
Bayer
Foundation date
20/07/1961
Sector
#PharmaSubsector
- #Therapeutics - Cell therapy
- #Therapeutics - Drug delivery
- #Therapeutics - Gene therapy
- #Therapeutics - Molecular diagnostics
- #Therapeutics - Small molecules
- #Therapeutics - Anti-infectives
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the eye
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
- #Pregnancy - childbirth and the puerperium
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobsMore info?
Contact us
Ellen Telleir
Communication Coordinator